We are live on ! Find out more
GCAC

Guardian Capital Advisors (Canada) Portfolio holdings

AUM $1.02B
1-Year Est. Return 25.29%
This Fund
S&P 500
This Quarter Est. Return
+4.5%
1 Year Est. Return
+25.29%
3 Year Est. Return
+26.14%
5 Year Est. Return
+60.9%
10 Year Est. Return
+667.11%
AUM
$976M
AUM Growth
+$100M
Cap. Flow
+$116M
Cap. Flow %
11.86%
Top 10 Hldgs %
39.88%
Holding
180
New
9
Increased
80
Reduced
62
Closed
8

Top Buys

Rank Stock Value
1
ABCL icon
AbCellera Biologics
ABCL
+$110M
2
FTS icon
Fortis
FTS
+$2.87M
3
AAPL icon
Apple
AAPL
+$1.24M
4
CLF icon
Cleveland-Cliffs
CLF
+$928K
5
COST icon
Costco
COST
+$676K

Top Sells

Rank Stock Value
1
BCE icon
BCE
BCE
+$2.88M
2
ORAN
Orange
ORAN
+$953K
3
UL icon
Unilever
UL
+$776K
4
ORCL icon
Oracle
ORCL
+$703K
5
GLW icon
Corning
GLW
+$596K

Sector Composition

Rank Sector Weight
1 Financials 30.51%
2 Healthcare 16.52%
3 Technology 11.04%
4 Energy 8.9%
5 Communication Services 7.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LMT icon
176
Lockheed Martin
LMT
$135B
-550
Closed -$214K
MCK icon
177
McKesson
MCK
$102B
-2,485
Closed -$474K
REGN icon
178
Regeneron Pharmaceuticals
REGN
$80.9B
-1,100
Closed -$529K
TLT icon
179
iShares 20+ Year Treasury Bond ETF
TLT
$41.7B
-2,900
Closed -$400K
WHR icon
180
Whirlpool
WHR
$2.82B
-1,100
Closed -$255K

Similar funds

Guardian Capital Advisors (Canada)'s Q2 2021 Portfolio in Review

As of Q2 2021, Guardian Capital Advisors (Canada) held 180 positions worth $976M, up 11% from $876M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Guardian Capital Advisors (Canada) deployed $116M of net new capital in Q2 2021, opening 9 new positions and adding to 80 existing holdings. Its largest new stake was AbCellera Biologics: 3,975,994 shares worth $81.4M.

By sector, the portfolio is most concentrated in Financials at 31% of assets, down from 36% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was BCE, an estimated $2.88M trimmed.

  • Guardian Capital Advisors (Canada)'s largest Q2 2021 buy was AbCellera Biologics: 3,975,994 shares worth $81.4M.
  • Guardian Capital Advisors (Canada) added most to Fortis in Q2 2021, an estimated $2.87M increase.
  • Guardian Capital Advisors (Canada)'s biggest Q2 2021 reduction was BCE, cutting an estimated $2.88M.
  • Guardian Capital Advisors (Canada) fully exited Regeneron Pharmaceuticals in Q2 2021, selling an estimated $529K.
  • Guardian Capital Advisors (Canada)'s ten largest holdings make up 40% of its $976M portfolio in Q2 2021.
  • Guardian Capital Advisors (Canada) opened 9 new positions and closed 8 in Q2 2021.
  • Guardian Capital Advisors (Canada)'s portfolio value rose 11% quarter-over-quarter to $976M.

Based on Guardian Capital Advisors (Canada)'s 13F filing for Q2 2021, filed 17 Aug 2021.